Bank of New York Mellon’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-127,706
Closed -$1.13M 4502
2022
Q3
$1.13M Sell
127,706
-17,075
-12% -$215K ﹤0.01% 3142
2022
Q2
$1.83M Buy
144,781
+3,624
+3% +$46.1K ﹤0.01% 2886
2022
Q1
$2.67M Buy
141,157
+2,603
+2% +$66.3K ﹤0.01% 2782
2021
Q4
$4.86M Sell
138,554
-197
-0.1% -$6.4K ﹤0.01% 2480
2021
Q3
$5.08M Buy
138,751
+4,931
+4% +$194K ﹤0.01% 2477
2021
Q2
$5.26M Sell
133,820
-12,033
-8% -$347K ﹤0.01% 2461
2021
Q1
$4.12M Buy
145,853
+19,267
+15% +$614K ﹤0.01% 2532
2020
Q4
$4.05M Buy
126,586
+3,239
+3% +$99.6K ﹤0.01% 2454
2020
Q3
$3.98M Sell
123,347
-15
-0% -$468 ﹤0.01% 2337
2020
Q2
$3.4M Buy
123,362
+31,713
+35% +$688K ﹤0.01% 2406
2020
Q1
$1.64M Buy
91,649
+1,511
+2% +$36.4K ﹤0.01% 2649
2019
Q4
$2.26M Sell
90,138
-643
-0.7% -$14.1K ﹤0.01% 2752
2019
Q3
$1.62M Buy
90,781
+4,984
+6% +$104K ﹤0.01% 2869
2019
Q2
$1.89M Buy
85,797
+11,268
+15% +$322K ﹤0.01% 2824
2019
Q1
$2.28M Buy
74,529
+9,199
+14% +$229K ﹤0.01% 2712
2018
Q4
$1.51M Buy
+65,330
New +$2.03M ﹤0.01% 2876

Other funds holding HCM

Bank of New York Mellon's HCM Position: Q4 2022 in Review

Bank of New York Mellon sold out of HUTCHMED (HCM) in Q4 2022, closing a stake of 127,706 shares — an estimated $1.13M sold.

Bank of New York Mellon first reported a position in HCM in Q4 2018 and held it in 16 quarters. The position peaked at $5.26M in Q2 2021. 84 funds tracked by Wall St. Rank hold HCM as of Q4 2022.

  • Bank of New York Mellon reported no remaining HUTCHMED position as of Q4 2022 after selling out during the quarter.
  • Bank of New York Mellon sold 127,706 HUTCHMED shares in Q4 2022, an estimated $1.13M.
  • Bank of New York Mellon first reported a position in HUTCHMED in Q4 2018 and held it in 16 quarters.
  • Bank of New York Mellon's HUTCHMED position peaked at $5.26M in Q2 2021.
  • 84 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2022.

Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.